Regenexx

Regenexx has published approximately 44% of the worlds research on the use of bone marrow concentrate for orthopedic conditions worldwide and holds 15 patents on various Interventional-Orthopedic technologies and protocols. Regenexx patients receive the full benefit of our unique understanding of regenerative treatments for orthopedic injuries.